(Q40489721)

21 September 2017

A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients (English)

1 reference

21 September 2017

0 references

John GT

1

1 reference

21 September 2017

Manivannan J

2

1 reference

21 September 2017

Chandy S

3

1 reference

21 September 2017

Peter S

4

1 reference

21 September 2017

Fleming DH

5

1 reference

21 September 2017

Chandy SJ

6

1 reference

21 September 2017

Balakrishnan N

7

1 reference

21 September 2017

Krishnamurthy K

8

1 reference

21 September 2017

Kirubakaran MG

9

1 reference

21 September 2017

Jacob CK

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Transplantation Proceedings

21 September 2017

1 reference

21 September 2017

37

1 reference

21 September 2017

10

1 reference

21 September 2017

4303-4305

1 reference

Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

Epidemiology of systemic mycoses among renal-transplant recipients in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

Risk factors for post-transplant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

End-stage renal disease in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

Leflunomide therapy for cytomegalovirus disease in renal allograft recepients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.116

10.1016/J.TRANSPROCEED.2005.10.116

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference